The company has not filed an annual or quarterly report since its FY2023 20-F, filed Mar 25, 2024. Its latest SEC filing is a 15-15D from Jul 22, 2024.
20-F for FY2023, filed Mar 25, 2024
The sections below describe the company as of the FY2023 annual report.
Provides property and casualty reinsurance to insurance companies worldwide, alongside specialty and life and health reinsurance.
20-F for FY2023, filed Mar 25, 2024
$9.1B
20-F for FY2023, filed Mar 25, 2024
$9.1B ↗
Provides reinsurance to insurance companies, working through brokers and through direct relationships with insurance-company clients.
20-F for FY2023, filed Mar 25, 2024
Yes. It kept 25 cents of every revenue dollar as net income in FY2023.
20-F for FY2023, filed Mar 25, 2024
20-F for FY2023, filed Mar 25, 2024
$2.3BView ↗
Grew. Revenue grew 16% in 4 years, from $7.9B in FY2019 to $9.1B in FY2023, about 4% a year.
Life and Health scope
The latest report includes financial reinsurance solutions in Life and Health, whereas the older segment description listed mortality, morbidity and longevity.
20-F for FY2020, filed Feb 25, 2021 20-F for FY2023, filed Mar 25, 2024The Company monitors the performance of its operations in three worldwide business units comprised of Property & Casualty (P&C), Specialty…View ↗
The Company monitors the performance of its operations in three worldwide business units comprised of Property & Casualty (P&C), Specialty…View ↗
Competes with Munich Re, Swiss Re, Hannover Re, SCOR, Transatlantic, GenRe, Everest Re, RenRe, and RGA
20-F for FY2023, filed Mar 25, 2024Management believes that the Company’s major competitors for the Company's Non-life business are the larger European, U.S. and…View ↗
Loading...
